Wei Xu

Area of research

Cancer Research · Molecular Biology

Research interest

Research focused on Cancer research and Biomarker, with related work in Cancer stem cell, KRAS, Pancreatic cancer. Notable publications include 'Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis', 'Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells', and 'The UCA1/KRAS axis promotes human pancreatic ductal adenocarcinoma stem cell properties and tumor growth'.

h-index

—

citations

181

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis

Journal of Cancer 2019cited by 83position: middledoi

The UCA1/KRAS axis promotes human pancreatic ductal adenocarcinoma stem cell properties and tumor growth.

PubMed 2019cited by 35position: middle

Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells

Cell Death and Disease 2013cited by 63position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Cancer Research · Molecular Biology →